Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 47 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 8916159

    Selenocysteine mediated hybrid antibody molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  2. US 8916175

    Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  3. US 8916596

    Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  4. US 8916570

    A3 adenosine receptor agonists and antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  5. US 8912146

    Derivatives of APF and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  6. US 8912214

    Use of Chk2 kinase inhibitors for cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  7. US 8907060

    Mutated Pseudomonas exotoxins with reduced antigenicity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  8. US 8906384

    Antiviral activity of bovine type III interferon against foot-and-mouth disease virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  9. US 8900599

    Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

  10. US 8883448

    Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  11. US 8877914

    Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  12. US 8871789

    Method of preventing or treating viral infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  13. US 8871206

    Anti-human folate receptor beta antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  14. US 8871902

    Immunogenic POTE peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  15. US 8871906

    Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted

  16. US 8865672

    Prevention of tissue ischemia and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  17. US 8858938

    Human monoclonal antibodies against Hendra and Nipah viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  18. US 8858959

    Gel vaccine delivery system for treating poultry

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  19. US 8859585

    Scopolamine for the treatment of depression and anxiety

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  20. US 8859207

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  21. US 8853160

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  22. US 8853277

    Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  23. US 8846055

    Virulence determinant within the E2 structural glycoprotein of classical swine fever virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  24. US 8846389

    AAV4 vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.